- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03753516
Pelvic Floor Support After Laparoscopic Hysterectomy for Benign Conditions: A Randomized Controlled Trial Comparing Vaginal Cuff Closure Techniques
May 26, 2020 updated by: Walter Reed National Military Medical Center
The purpose of this study is to learn about the effect of different vaginal cuff closure techniques on pelvic support after laparoscopic hysterectomy and robotic assisted laparoscopic hysterectomy for benign gynecologic conditions.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
78
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Scott Endicott, MD
- Phone Number: 301-400-2140
- Email: scott.p.endicott.mil@mail.mil
Study Locations
-
-
Maryland
-
Bethesda, Maryland, United States, 20889
- Recruiting
- Walter Reed National Military Medical Center
-
Contact:
- Scott Endicott, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women over 18 years of age undergoing total laparoscopic hysterectomy and robotic assisted total laparoscopic hysterectomy for benign disease.
- Subjects must be able to self-consent.
- Department of Defense beneficiary
Exclusion Criteria:
- Patients will be excluded if they undergo a concurrent procedure for prolapse.
- If the indication for the procedure is a malignancy.
- Those that plan to leave the area in less than 1 year will not be included.
- Pop-Q Point C of >-4
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Laparoscopic - Vaginal Cuff Closure
|
All participants are scheduled for either laparoscopic or robotic assisted total hysterectomy.
At the end of the hysterectomy the vaginal cuff is closed.
In this arm the vaginal cuff will be close laparoscopically using an 0-Barbed suture.
|
ACTIVE_COMPARATOR: Vaginal - Vaginal Cuff Closure
|
All participants are scheduled for either laparoscopic or robotic assisted total hysterectomy.
At the end of the hysterectomy the vaginal cuff is closed.
In this arm the vaginal cuff will be close vaginally using an 0-Vicryl suture in a vertical fashion.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pelvic Organ Prolapse - Quantification Point C
Time Frame: 6-8 weeks post op
|
The Pelvic Organ Prolapse - Quantification system is a validated way to measure pelvic organ prolapse.
The investigators will measure this post op at 6-8 weeks to see if prolapse is better using one method vs the other.
|
6-8 weeks post op
|
Pelvic Organ Prolapse - Quantification Point C
Time Frame: 1 year post op
|
The Pelvic Organ Prolapse - Quantification system is a validated way to measure pelvic organ prolapse.
The investigators will measure this post op at 1 year to see if prolapse is better using one method vs the other.
|
1 year post op
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Vaginal Cuff Dehiscence
Time Frame: 1 year
|
1 year
|
Vaginal Cuff Abscess
Time Frame: 1 year
|
1 year
|
Vaginal Cuff Cellulitis
Time Frame: 1 year
|
1 year
|
Vaginal Cuff bleeding
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 1, 2017
Primary Completion (ANTICIPATED)
December 1, 2020
Study Completion (ANTICIPATED)
December 1, 2020
Study Registration Dates
First Submitted
November 20, 2018
First Submitted That Met QC Criteria
November 21, 2018
First Posted (ACTUAL)
November 27, 2018
Study Record Updates
Last Update Posted (ACTUAL)
May 27, 2020
Last Update Submitted That Met QC Criteria
May 26, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- WRNMMC-2017-0055
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pelvic Organ Prolapse
-
Coloplast A/SCompletedPelvic Organ Prolapse (POP)United States
-
University of CalgaryAlberta Health services; Cook Group IncorporatedCompletedAnterior Pelvic Organ ProlapseCanada
-
University of British ColumbiaCompletedPelvic Organ Prolapse, Patient EducationCanada
-
Unity Health TorontoUnknownVoiding Dysfunction After Pelvic Organ Prolapse SurgeryCanada
-
University of MelbourneCompletedVaginal Hysterectomy | Pelvic Organ Prolapse Vaginal SurgeryAustralia
-
Nykøbing Falster County HospitalZealand University Hospital; University Hospital, Gentofte, Copenhagen; Copenhagen...UnknownBenign Hysterectomy | Postoperative Pelvic Organ Prolapse | Suspension
-
Mackay Medical CollegeRecruitingPelvic Organ Prolapse | Stage III and IV High Grade Pelvic Organ ProlapseTaiwan
-
Peking Union Medical College HospitalUnknown
-
Gaziosmanpasa Research and Education HospitalRecruitingPatients With Pelvic Organ Prolapse | Pectopexy | Lateral Suspension | Pop-q | Pisq-12Turkey
-
Charles University, Czech RepublicUnknownPelvic Organ Prolapse RecurrenceCzech Republic
Clinical Trials on Laparoscopic - Vaginal Cuff Closure
-
Istanbul UniversityUniversity of SurreyCompletedTotal Laparoscopic Hysterectomy | Benign ConditionsTurkey
-
Bridgeport HospitalCompleted
-
Cairo UniversityUnknown
-
Brigham and Women's HospitalCompletedClosure of Vaginal Cuff at Laparoscopic HysterectomyUnited States
-
Aesculap AGB.Braun Surgical SARecruitingCervical Cancer | Endometriosis | Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Uterine Prolapse | Uterine Cancer | Abnormal Uterine BleedingGermany, Spain
-
Mansoura UniversityRecruitingUterine DiseasesEgypt
-
Ethicon, Inc.CompletedBariatric - Sleeve Gastrectomy Staple Line Reinforcement | Gynecology - Vaginal Cuff ClosureItaly, United States, Germany
-
El-Galaa Military Medical ComplexCompletedVaginal Infection | Vaginal Cuff Dehiscence | Vaginal HematomaEgypt
-
Brigham and Women's HospitalWithdrawnPain | Dyspareunia | Surgical Mesh
-
Milton S. Hershey Medical CenterCompletedHysterectomyUnited States